Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122141) titled 'Determination of the Median Effective Dose of Remifentanil for Conscious Analgesic Gastroscopy with Concurrent Intravenous Lidocaine in High Aspiration-Risk Patients' on April 9.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Weifang People's Hospital

Condition: Reflux aspiration

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-01

Target Sample Size: Remifentanil:35;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=305918

Published by HT Digital Content Services with permission from Health D...